LYSOCIL
“This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 811087”.
LYSOCIL Excel in Rare Diseases Research: Focus on LYSOsomal - - PowerPoint PPT Presentation
LYSOCIL Excel in Rare Diseases Research: Focus on LYSOsomal Disorders and CILiopathies This project has received funding from the European Unions Horizon 2020 research and innovation programme under grant agreement No 811087.
“This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 811087”.
Proposal Title: Excel in Rare Diseases’ Research: Focus on LYSOsomal Disorders and CILiopathies Proposal Acronym: LYSOCIL Topic reference: WIDESPREAD-05-2017: Twinning Call Identifier: H2020-WIDESPREAD-2016-2017 Project Coordinators: Duarte Barral/Susana Lopes (CEDOC) Consortium: Dates: November 2018 - November 2021 Total investment: EUR 967,572.50
7 Research groups 13 Research groups 8 Research groups
Gregory Pazour University of Massachusetts (USA) Claire Hogg Royal Brompton and Harefield (UK) Miriam Schmidts Radboud University (NL) Frances Platt University
Oxford (UK) Paul Luzio University
Cambridge (UK) Margarida Laygue Raríssimas (PT)
LYSOCIL External Advisory Board
Duarte Barral: Membrane Traffic in Infection and Disease
Susana Lopes: Cilia Regulation and Disease Miguel Seabra: Molecular Mechanism
Paulo Pereira: Proteostasis and Proteolytic Signaling Otília Vieira: Lysosomes in Chronic Human Pathologies and Infection Cláudia Almeida: Neuronal Trafficking in Aging Helena Vieira: Cell Death and Disease
Heymut Omran: Molecular and functional analysis of primary ciliary dyskinesia (PCD) + Heike Olbrich + Niki Tomas Loges + Gerard Dougherty + Julia Wallmeier + Petra Pennekamp + Tabea Nöthe-Menchen + Sandra Cindric Martin Konrad: Inherited Renal Tubular Disorders Jens König: Cystic Kidney Diseases of the Childhood Karl Peter Schlingmann Inherited Renal Tubular Disorders Uwe Hansen: Electron Microscopy Frank Rutsch: Rare Pediatric Metabolic and Autoimmune Disorders Bernd Dworniczak: Human Genetics
Antonella De Matteis: Cell Biology and Disease Mechanisms + Leopoldo Staiano Roman Polishchuck: Advanced Microscopy and Imaging Core + Lena Polishchuck Carmine Settembre: Lysosomal Processes in Skeletal Development and Diseases + Giorgia Di Lorenzo Diego Medina: Lysosomal Calcium Signalling and Autophagy + Simone Di Paola Jlenia Monfregola: Modulating Cellular Clearance to Treat Human Disease (Andrea Ballabio group) Graciana Diez-Roux: TIGEM Scientific Office + Bianca Fontanella + Barbara Zimbardi Cristina Nicolina Sorrentino: Preclinical studies and Translational Unit
The overall aim is to strengthen the research and
innovation capacity of CEDOC, capacitating it to become a national and internationally-recognized Centre of Excellence in Chronic RD research and innovation.
To intensify intramural collaboration To strengthen the research quality and innovation, while promoting multidisciplinary projects within and beyond CEDOC To provide an exciting research environment for the training
the research and academic profile of CEDOC and of all the partners’ staff To foster the organization of outreach activities at local and national levels
Rare Diseases affect less than 1 in 2,000 newborns (30M people affected in Europe) and only 500/7000 have therapies
→ AXIS 1: Lysosome Biology and Lysosomal Disorders. (Otília Vieira, Miguel Seabra, Duarte Barral, Paulo Pereira, Cláudia Almeida) → AXIS 2: Cilia Biology, Primary and Motile Ciliopathies. (Susana Lopes, Duarte Barral) → AXIS 3: Autophagy, Mitophagy, Cell Metabolism and Implication in RDs. (Helena Vieira)
→ Lysosomal-Storage Disorders: rare and recessively inherited metabolic dysfunctions. Often associated with severe neurodegeneration, mental decline, cognitive problems and behavioral abnormalities. → Griscelli Syndrome: divided in 3 sub-types - GS1, GS2 and GS3 - caused by mutations in MYO5A, RAB27A or
hair and skin, and in the case of GS2 also immune dysfunction. → Hermansky-Pudlak Syndrome: Patients present a combination of albinism and bleeding diathesis. → Choroideremia: rare X-linked retinal degeneration caused by mutations in Rab-escort protein 1 (REP1). This disease is a good candidate for treatment by gene therapy.
Lysosomal Disorders
→ Primary ciliary dyskinesia: rare genetic disorder caused by inherited defects in motile ciliary
infections, it typically progresses to bronchiectasis and can result in chronic lung failure in adulthood. → Polycystic kidney disease: genetic disorder in which the renal tubules become structurally abnormal, resulting in the development and growth of multiple cysts in the kidneys. → Joubert syndrome: disorder
brain development that affects many parts of the body and it is characterized by the absence
underdevelopment of the cerebellar vermis and a malformed brain stem.
Ciliopathies
Research career mentoring programme Short-term missions (e.g. CEDOC Research Funding Office) Virtual think tanks Training workshops (lysosome biology, drug screening, transmission electron microscopy and outreach & fundraising) Summer school Winter retreats LYSOCIL satellite meetings CEDOC open day on the Rare Disease day - 29th February 202 Student annual competition on Rare Diseases for the presentation of creative ideas around these diseases Fundraising - research on Rare Diseases Staff exchange programme
Training on distinguishing true genetic PCD from secondary ciliary dyskinesia
Feb/Mar 2019
Training on induced pluripotent stem cells (iPSC)
May/Jul 2019
Training in immunostainings pioneered by Omran’ lab
Sep 2019
Training on the analysis of lysosome morphological changes
Nov 2019
Training on mitophagy analysis under the context of mitochondrial diseases
Jan 2020
Training on cross-talk between cilia and autophagy
Mar 2020
Training on the characterization of lysosome-related organelles
May/Aug 2020
Genotyping for the identification of genes that cause ciliopathies
Dec/Jan 2021
Increase the number of publications in top 10% peer reviewed journals and citations Increase the number and success rate of national and international research grant applications, the number of oral or poster communications during scientific meetings and of invitations to national and international conferences Increase the number of new collaborations within and outside LYSOCIL, of new international researchers and PhD students, and of PhD students and post-docs with international fellowships Increase the number of local, national and international outreach activities, of participants in outreach events, of newsletter and social networks’ followers and of online and printed media pieces